Coupled D dimer and fibrinogen levels during thrombolytic therapy of venous thromboembolism
- 1 February 1992
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 65 (3) , 457-462
- https://doi.org/10.1016/0049-3848(92)90176-b
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation.Circulation, 1990
- Use of a new removable vena cava filter in order to prevent pulmonary emblism in patients submitted to thrombolysisEuropean Heart Journal, 1990
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Evolution of plasma specific fibrin degradation products during thrombolytic therapy in patients with thrombo-embolismThrombosis Research, 1988
- FIBRIN DEGRADATION PRODUCTS ARE NOT SPECIFIC MARKERS FOR THROMBOLYSIS IN MYOCARDIAL INFARCTIONThe Lancet, 1987
- Specific Determination and Identification of Cross-Linked Fibrin Degradation Products in Patients Under Thrombolytic Therapy for Myocardial InfarctionSeminars in Thrombosis and Hemostasis, 1987
- Controversies of Different Regimens of Thrombolytic Therapy in Acute Pulmonary EmbolismSeminars in Thrombosis and Hemostasis, 1987
- Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction.Circulation, 1986
- Elevated serum D dimer: A degradation product of cross-linked fibrin (XDP) after intravenous streptokinase during acute myocardial infarctionJournal of the American College of Cardiology, 1986
- Plasma Fibrinogen and its Fragments during Streptokinase TreatmentBritish Journal of Haematology, 1974